Rock Springs Capital Management LP 89bio, Inc. Transaction History
Rock Springs Capital Management LP
- $2.94 Billion
- Q3 2024
A detailed history of Rock Springs Capital Management LP transactions in 89bio, Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 164,500 shares of ETNB stock, worth $1.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
164,500Holding current value
$1.8 Million% of portfolio
0.06%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ETNB
# of Institutions
166Shares Held
111MCall Options Held
73.6KPut Options Held
1.19M-
Janus Henderson Group PLC London, X015.2MShares$166 Million0.06% of portfolio
-
Ra Capital Management, L.P. Boston, MA14.2MShares$155 Million1.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY7.99MShares$87.3 Million2.33% of portfolio
-
Rtw Investments, LP New York, NY7.38MShares$80.6 Million0.87% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$76.7 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $508M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...